1. Home
  2. CORT vs FRHC Comparison

CORT vs FRHC Comparison

Compare CORT & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • FRHC
  • Stock Information
  • Founded
  • CORT 1998
  • FRHC N/A
  • Country
  • CORT United States
  • FRHC United States
  • Employees
  • CORT N/A
  • FRHC N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • FRHC Investment Bankers/Brokers/Service
  • Sector
  • CORT Health Care
  • FRHC Finance
  • Exchange
  • CORT Nasdaq
  • FRHC Nasdaq
  • Market Cap
  • CORT 7.5B
  • FRHC 9.3B
  • IPO Year
  • CORT N/A
  • FRHC N/A
  • Fundamental
  • Price
  • CORT $73.22
  • FRHC $145.68
  • Analyst Decision
  • CORT Strong Buy
  • FRHC
  • Analyst Count
  • CORT 4
  • FRHC 0
  • Target Price
  • CORT $142.00
  • FRHC N/A
  • AVG Volume (30 Days)
  • CORT 1.9M
  • FRHC 210.8K
  • Earning Date
  • CORT 07-28-2025
  • FRHC 08-08-2025
  • Dividend Yield
  • CORT N/A
  • FRHC N/A
  • EPS Growth
  • CORT 8.36
  • FRHC N/A
  • EPS
  • CORT 1.14
  • FRHC 1.40
  • Revenue
  • CORT $685,446,000.00
  • FRHC $1,462,948,000.00
  • Revenue This Year
  • CORT $35.83
  • FRHC N/A
  • Revenue Next Year
  • CORT $35.24
  • FRHC N/A
  • P/E Ratio
  • CORT $64.14
  • FRHC $102.90
  • Revenue Growth
  • CORT 30.93
  • FRHC 33.85
  • 52 Week Low
  • CORT $29.42
  • FRHC $71.88
  • 52 Week High
  • CORT $117.33
  • FRHC $185.00
  • Technical
  • Relative Strength Index (RSI)
  • CORT 51.47
  • FRHC 44.20
  • Support Level
  • CORT $72.48
  • FRHC $141.60
  • Resistance Level
  • CORT $77.42
  • FRHC $146.42
  • Average True Range (ATR)
  • CORT 2.61
  • FRHC 5.80
  • MACD
  • CORT 0.27
  • FRHC -0.55
  • Stochastic Oscillator
  • CORT 47.96
  • FRHC 34.30

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

Share on Social Networks: